USA - engelsk - NLM (National Library of Medicine)

norbrook laboratories limited - oxytetracycline hydrochloride (unii: 4u7k4n52zm) (oxytetracycline anhydrous - unii:slf0d9077s) -

USA - engelsk - NLM (National Library of Medicine)

bluebay shandong co.,ltd - oxytetracycline hydrochloride (unii: 4u7k4n52zm) (oxytetracycline hydrochloride - unii:4u7k4n52zm) -

USA - engelsk - NLM (National Library of Medicine)

pharmgate animal health - chlortetracycline hydrochloride (unii: o1gx33on8r) (chlortetracycline - unii:wck1kiq23q) - chlortetracycline hydrochloride 0.141 g in 1 g - indications and directions for use medicate chickens and turkeys continuously at the first clinical signs of disease and continue for 7 to 14 consecutive days. the dosage ranges permitted provide for different levels based on the severity of the infection. if improvement is not noted in 24-48 hours, consult a veterinarian or a diagnostic laboratory to determine diagnoses and for advice regarding the optimal level of the drug where ranges are permitted. water medicators: dissolve the contents of one 25.6 oz packet in 100 oz of fresh water to prepare a stock solution, that when metered at the rate of 1 oz per gallon of drinking water, will deliver 1000 mg of chlortetracycline hcl per gallon. at this rate, a gallon of drinking water will treat a 100 lb pig or a 100 lb calf at the rate of 10 mg per lb of body weight for one day.

USA - engelsk - NLM (National Library of Medicine)

zoetis inc. - oxytetracycline hydrochloride (unii: 4u7k4n52zm) (oxytetracycline anhydrous - unii:slf0d9077s), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - oxytetracycline hydrochloride 5 mg in 1 g - terramycin is indicated for the prophylaxis and local treatment of superficial ocular infections due to oxytetracycline and polymyxin-sensitive organisms, including infections due to streptococci, rickettsiae, e. coli, and a. aerogenes, such as conjunctivitis, keratitis, pink eye, corneal ulcer, blepharitis in dogs, cats, cattle, sheep, and horses; ocular infections due to secondary bacterial complications of distemper in dogs, and bacterial inflammatory conditions which  may occur secondary to other infectious diseases in the above species.

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dox-al australia pty ltd - oxytetracycline as oxytetracycline hydrochloride - oral powder, pre-mix - oxytetracycline as oxytetracycline hydrochloride antibiotic active 200.0 g/kg - nutrition & metabolism - cattle | pigs | poultry | beef | boar | bos indicus | bos taurus | bovine | breeders | broiler | buffalo | bull | bullock | calf - chronic respiratory disease complex | leptospirosis | mycoplasma hyopneumoniae | organisms sensitive to oxytetracycline | enteric bacterial infection | l. hardjo | l. interrogans | l. pomona | l. tarassovi | reduction of lung lesions | respiratory disease | respiratory infection | swine enzootic pneumonia

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

allied animal health pty ltd - oxytetracycline hydrochloride - oral powder, pre-mix - oxytetracycline hydrochloride antibiotic active 1000.0 g/kg - antibiotic & related - calf | cattle | pigs | poultry | beef | beef calf | boar | bos indicus | bos taurus | bovine | breeders | broiler | buffalo | bu - organisms sensitive to oxytetracycline | enteric bacterial infection | respiratory infection

Kenya - engelsk - Pharmacy and Poisons Board

goodman agencies ltd. 6th floor, goodman tower, waiyaki way, westlands, - oxytetracycline hydrochloride - powder for syrup - oxytetracycline hydrochloride, 500mg per gm - tetracyclines

Belgia - tysk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kela - oxytetracycline hydrochloride - pulver zum eingeben über das trinkwasser/die milch - 863,20 mg/g - oxytetracycline hydrochloride 863.2 mg/g - oxytetracycline - rind; schwein

USA - engelsk - NLM (National Library of Medicine)

heritage pharmaceuticals inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of achromycin v (tetracycline hcl capsules, usp) and other antibacterial drugs, achromycin v (tetracycline hcl capsules, usp) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. achromycin v (tetracycline hcl capsules, usp) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: achromycin v (tetracycline hcl capsules, usp) should not be used for streptococcal disease unless the organism ha

USA - engelsk - NLM (National Library of Medicine)

physicians total care, inc. - bismuth subcitrate potassium (unii: r3o80h60kx) (bismuth - unii:u015tt5i8h), metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e), tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - bismuth subcitrate potassium 140 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of pylera and other antibacterial drugs, pylera should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. pylera in combination with omeprazole are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate h. pylori . the eradication of helicobacter pylori has been shown to reduce the risk of duodenal ulcer recurrence. do not administer methoxyflurane to patients taking pylera. the concurrent use of tetracycline hydrochloride, a component of pylera, with methoxyflurane has been reported to resu